MedPath

LABORATORI GUIDOTTI SPA

๐Ÿ‡ฎ๐Ÿ‡นItaly
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.labguidotti.it

Clinical Trials

1

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Rociverine Tablets

Product Name
้‡Œๆ‹‰้€š
Approval Number
ๅ›ฝ่ฏๅ‡†ๅญ—HJ20150471
Approval Date
Mar 21, 2024
NMPA

Rociverine Tablets

Product Name
้‡Œๆ‹‰้€š
Approval Number
H20150471
Approval Date
May 10, 2019
NMPA

Clinical Trials

Observational Study On The Characterization Of 24-Hour Symptoms In Patients With COPD

Completed
Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2017-04-10
Last Posted Date
2018-08-22
Lead Sponsor
Laboratori Guidotti S.p.A.
Target Recruit Count
683
Registration Number
NCT03105999
Locations
๐Ÿ‡ฎ๐Ÿ‡น

Ospedale Ecclesiastico Miulli - Fisiopatologia Respiratoria, Acquaviva delle Fonti, Bari, Italy

๐Ÿ‡ฎ๐Ÿ‡น

A.O. Mellino Mellini - U.O. Fisiopatologia Respiratoria, Chiari, Brescia, Italy

๐Ÿ‡ฎ๐Ÿ‡น

Clinica Padre Pio - Medicina, Mondragone, Caserta, Italy

and more 37 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.